Which has stronger earnings and valuation, RKTO or XBIT?

XBiotech is trading at a lower price-to-earnings ratio than Rocket One Inc. Common Stock, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Rocket One Inc. Common Stock N/A N/A -$12.47M -$0.80 N/A XBiotech N/A N/A -$45.54M -$1.32 N/A

Is RKTO or XBIT more profitable?

XBiotech's return on equity of -26.10% beat Rocket One Inc. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Rocket One Inc. Common Stock N/A -165.25% -143.61% XBiotech N/A -26.10% -25.06%

Is RKTO or IBIO more profitable?

iBio's return on equity of -53.86% beat Rocket One Inc. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Rocket One Inc. Common Stock N/A -165.25% -143.61% iBio N/A -53.86% -46.48%

Is RKTO or TLPH more profitable?

Talphera's return on equity of -92.98% beat Rocket One Inc. Common Stock's return on equity. Company Net Margins Return on Equity Return on Assets Rocket One Inc. Common Stock N/A -165.25% -143.61% Talphera N/A -92.98% -53.22%

Rocket One Inc. Common Stock (RKTO) Competitors

$0.76 -0.02 (-2.68%)

As of 04:00 PM Eastern

Compare

RKTO vs. UPXI, XBIT, SPRO, IBIO, and TLPH

Should you buy Rocket One Inc. Common Stock stock or one of its competitors? MarketBeat compares Rocket One Inc. Common Stock with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Rocket One Inc. Common Stock include Upexi (UPXI), XBiotech (XBIT), Spero Therapeutics (SPRO), iBio (IBIO), and Talphera (TLPH). These companies are all part of the "pharmaceutical products" industry.

How does Rocket One Inc. Common Stock compare to Upexi?

Rocket One Inc. Common Stock (NASDAQ:RKTO) and Upexi (NASDAQ:UPXI) are both small-cap pharmaceutical products companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, valuation, earnings, profitability, risk, institutional ownership and media sentiment.

Rocket One Inc. Common Stock has a beta of 0.93, meaning that its stock price is 7% less volatile than the broader market. Comparatively, Upexi has a beta of -0.29, meaning that its stock price is 129% less volatile than the broader market.

In the previous week, Rocket One Inc. Common Stock and Rocket One Inc. Common Stock both had 2 articles in the media. Upexi's average media sentiment score of 1.28 beat Rocket One Inc. Common Stock's score of 0.30 indicating that Upexi is being referred to more favorably in the news media.

Company	Overall Sentiment
Rocket One Inc. Common Stock	Neutral
Upexi	Positive

Rocket One Inc. Common Stock presently has a consensus target price of $5.00, suggesting a potential upside of 558.76%. Upexi has a consensus target price of $8.10, suggesting a potential upside of 920.79%. Given Upexi's stronger consensus rating and higher probable upside, analysts plainly believe Upexi is more favorable than Rocket One Inc. Common Stock.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rocket One Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Upexi	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Rocket One Inc. Common Stock has higher earnings, but lower revenue than Upexi. Upexi is trading at a lower price-to-earnings ratio than Rocket One Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rocket One Inc. Common Stock	N/A	N/A	-$12.47M	-$0.80	N/A
Upexi	$15.81M	3.95	-$13.68M	-$0.62	N/A

Rocket One Inc. Common Stock has a net margin of 0.00% compared to Upexi's net margin of -874.00%. Upexi's return on equity of -66.70% beat Rocket One Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rocket One Inc. Common Stock	N/A	-165.25%	-143.61%
Upexi	-874.00%	-66.70%	-19.56%

7.1% of Rocket One Inc. Common Stock shares are owned by institutional investors. Comparatively, 5.7% of Upexi shares are owned by institutional investors. 6.9% of Rocket One Inc. Common Stock shares are owned by insiders. Comparatively, 9.0% of Upexi shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Upexi beats Rocket One Inc. Common Stock on 9 of the 14 factors compared between the two stocks.

How does Rocket One Inc. Common Stock compare to XBiotech?

Rocket One Inc. Common Stock (NASDAQ:RKTO) and XBiotech (NASDAQ:XBIT) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, dividends, risk, institutional ownership, profitability, analyst recommendations, valuation and media sentiment.

In the previous week, Rocket One Inc. Common Stock had 1 more articles in the media than XBiotech. MarketBeat recorded 2 mentions for Rocket One Inc. Common Stock and 1 mentions for XBiotech. XBiotech's average media sentiment score of 1.87 beat Rocket One Inc. Common Stock's score of 0.30 indicating that XBiotech is being referred to more favorably in the news media.

Company	Overall Sentiment
Rocket One Inc. Common Stock	Neutral
XBiotech	Very Positive

Rocket One Inc. Common Stock has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market. Comparatively, XBiotech has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

XBiotech is trading at a lower price-to-earnings ratio than Rocket One Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rocket One Inc. Common Stock	N/A	N/A	-$12.47M	-$0.80	N/A
XBiotech	N/A	N/A	-$45.54M	-$1.32	N/A

Rocket One Inc. Common Stock presently has a consensus target price of $5.00, indicating a potential upside of 558.76%. Given Rocket One Inc. Common Stock's stronger consensus rating and higher probable upside, equities analysts plainly believe Rocket One Inc. Common Stock is more favorable than XBiotech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rocket One Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
XBiotech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

XBiotech's return on equity of -26.10% beat Rocket One Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rocket One Inc. Common Stock	N/A	-165.25%	-143.61%
XBiotech	N/A	-26.10%	-25.06%

7.1% of Rocket One Inc. Common Stock shares are owned by institutional investors. Comparatively, 55.7% of XBiotech shares are owned by institutional investors. 6.9% of Rocket One Inc. Common Stock shares are owned by company insiders. Comparatively, 30.8% of XBiotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Rocket One Inc. Common Stock beats XBiotech on 8 of the 13 factors compared between the two stocks.

How does Rocket One Inc. Common Stock compare to Spero Therapeutics?

Rocket One Inc. Common Stock (NASDAQ:RKTO) and Spero Therapeutics (NASDAQ:SPRO) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, risk, media sentiment, valuation, institutional ownership, profitability, analyst recommendations and dividends.

Spero Therapeutics has a net margin of 24.90% compared to Rocket One Inc. Common Stock's net margin of 0.00%. Spero Therapeutics' return on equity of 35.58% beat Rocket One Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rocket One Inc. Common Stock	N/A	-165.25%	-143.61%
Spero Therapeutics	24.90%	35.58%	24.95%

Rocket One Inc. Common Stock has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market. Comparatively, Spero Therapeutics has a beta of 1.49, indicating that its stock price is 49% more volatile than the broader market.

Rocket One Inc. Common Stock presently has a consensus target price of $5.00, suggesting a potential upside of 558.76%. Given Rocket One Inc. Common Stock's stronger consensus rating and higher possible upside, equities analysts clearly believe Rocket One Inc. Common Stock is more favorable than Spero Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rocket One Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Spero Therapeutics	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Spero Therapeutics had 2 more articles in the media than Rocket One Inc. Common Stock. MarketBeat recorded 4 mentions for Spero Therapeutics and 2 mentions for Rocket One Inc. Common Stock. Spero Therapeutics' average media sentiment score of 0.84 beat Rocket One Inc. Common Stock's score of 0.30 indicating that Spero Therapeutics is being referred to more favorably in the news media.

Company	Overall Sentiment
Rocket One Inc. Common Stock	Neutral
Spero Therapeutics	Positive

7.1% of Rocket One Inc. Common Stock shares are held by institutional investors. Comparatively, 25.6% of Spero Therapeutics shares are held by institutional investors. 6.9% of Rocket One Inc. Common Stock shares are held by insiders. Comparatively, 2.9% of Spero Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Spero Therapeutics has higher revenue and earnings than Rocket One Inc. Common Stock. Rocket One Inc. Common Stock is trading at a lower price-to-earnings ratio than Spero Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rocket One Inc. Common Stock	N/A	N/A	-$12.47M	-$0.80	N/A
Spero Therapeutics	$66.80M	1.03	$8.57M	$0.24	4.96

Summary

Spero Therapeutics beats Rocket One Inc. Common Stock on 11 of the 15 factors compared between the two stocks.

How does Rocket One Inc. Common Stock compare to iBio?

Rocket One Inc. Common Stock (NASDAQ:RKTO) and iBio (NASDAQ:IBIO) are both small-cap pharmaceutical products companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

In the previous week, Rocket One Inc. Common Stock and Rocket One Inc. Common Stock both had 2 articles in the media. iBio's average media sentiment score of 1.86 beat Rocket One Inc. Common Stock's score of 0.30 indicating that iBio is being referred to more favorably in the news media.

Company	Overall Sentiment
Rocket One Inc. Common Stock	Neutral
iBio	Very Positive

iBio's return on equity of -53.86% beat Rocket One Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rocket One Inc. Common Stock	N/A	-165.25%	-143.61%
iBio	N/A	-53.86%	-46.48%

Rocket One Inc. Common Stock has higher earnings, but lower revenue than iBio. iBio is trading at a lower price-to-earnings ratio than Rocket One Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rocket One Inc. Common Stock	N/A	N/A	-$12.47M	-$0.80	N/A
iBio	$400K	168.91	-$18.38M	-$0.58	N/A

7.1% of Rocket One Inc. Common Stock shares are held by institutional investors. Comparatively, 7.9% of iBio shares are held by institutional investors. 6.9% of Rocket One Inc. Common Stock shares are held by company insiders. Comparatively, 2.8% of iBio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Rocket One Inc. Common Stock currently has a consensus price target of $5.00, suggesting a potential upside of 558.76%. iBio has a consensus price target of $5.00, suggesting a potential upside of 267.65%. Given Rocket One Inc. Common Stock's higher probable upside, equities research analysts plainly believe Rocket One Inc. Common Stock is more favorable than iBio.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rocket One Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
iBio	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	3 Strong Buy rating(s)	3.13

Rocket One Inc. Common Stock has a beta of 0.93, indicating that its stock price is 7% less volatile than the broader market. Comparatively, iBio has a beta of 1.27, indicating that its stock price is 27% more volatile than the broader market.

Summary

iBio beats Rocket One Inc. Common Stock on 10 of the 14 factors compared between the two stocks.

How does Rocket One Inc. Common Stock compare to Talphera?

Rocket One Inc. Common Stock (NASDAQ:RKTO) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

Talphera's return on equity of -92.98% beat Rocket One Inc. Common Stock's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rocket One Inc. Common Stock	N/A	-165.25%	-143.61%
Talphera	N/A	-92.98%	-53.22%

Rocket One Inc. Common Stock presently has a consensus price target of $5.00, indicating a potential upside of 558.76%. Talphera has a consensus price target of $3.00, indicating a potential upside of 129.01%. Given Rocket One Inc. Common Stock's higher probable upside, research analysts plainly believe Rocket One Inc. Common Stock is more favorable than Talphera.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rocket One Inc. Common Stock	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Talphera	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Rocket One Inc. Common Stock has higher earnings, but lower revenue than Talphera. Talphera is trading at a lower price-to-earnings ratio than Rocket One Inc. Common Stock, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rocket One Inc. Common Stock	N/A	N/A	-$12.47M	-$0.80	N/A
Talphera	$1K	67,989.00	-$14.29M	-$0.31	N/A

7.1% of Rocket One Inc. Common Stock shares are owned by institutional investors. Comparatively, 37.7% of Talphera shares are owned by institutional investors. 6.9% of Rocket One Inc. Common Stock shares are owned by company insiders. Comparatively, 3.5% of Talphera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Rocket One Inc. Common Stock has a beta of 0.93, indicating that its share price is 7% less volatile than the broader market. Comparatively, Talphera has a beta of 0.7, indicating that its share price is 30% less volatile than the broader market.

In the previous week, Rocket One Inc. Common Stock and Rocket One Inc. Common Stock both had 2 articles in the media. Talphera's average media sentiment score of 1.23 beat Rocket One Inc. Common Stock's score of 0.30 indicating that Talphera is being referred to more favorably in the news media.

Company	Overall Sentiment
Rocket One Inc. Common Stock	Neutral
Talphera	Positive

Summary

Talphera beats Rocket One Inc. Common Stock on 8 of the 13 factors compared between the two stocks.

Get Rocket One Inc. Common Stock News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RKTO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RKTO vs. The Competition

Export

Metric	Rocket One Inc. Common Stock	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$16.94M	$3.70B	$7.04B	$11.98B
Dividend Yield	N/A	2.17%	2.66%	8.55%
P/E Ratio	-0.95	21.89	27.35	23.46
Price / Sales	N/A	300.25	578.12	106.51
Price / Cash	N/A	153.52	49.60	59.05
Price / Book	1.90	7.82	10.06	5.96
Net Income	-$12.47M	$23.81M	$3.60B	$336.43M
7 Day Performance	-8.23%	-4.11%	-1.77%	-2.79%
1 Month Performance	-21.11%	-8.15%	-4.37%	-5.86%
1 Year Performance	-41.62%	34.38%	19.57%	12.75%

Rocket One Inc. Common Stock Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RKTO Rocket One Inc. Common Stock	1.5416 of 5 stars	$0.76 -2.7%	$5.00 +558.8%	-40.5%	$16.94M	N/A	N/A	4	Short Interest Increase Gap Down
UPXI Upexi	2.1426 of 5 stars	$0.88 +3.9%	$8.10 +819.4%	-85.0%	$69.34M	$15.81M	N/A	130	Positive News Gap Down
XBIT XBiotech	0.8 of 5 stars	$2.27 +0.4%	N/A	-19.5%	$69.21M	N/A	N/A	100
SPRO Spero Therapeutics	1.6378 of 5 stars	$1.20 +1.3%	N/A	-48.0%	$69.19M	$66.80M	4.98	150
IBIO iBio	3.1247 of 5 stars	$1.39 -4.1%	$5.00 +259.7%	N/A	$69.06M	$400K	N/A	100	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RKTO) was last updated on 7/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rocket One Inc. Common Stock (RKTO) Competitors

RKTO vs. UPXI, XBIT, SPRO, IBIO, and TLPH

How does Rocket One Inc. Common Stock compare to Upexi?

Summary

How does Rocket One Inc. Common Stock compare to XBiotech?

Summary

How does Rocket One Inc. Common Stock compare to Spero Therapeutics?

Summary

How does Rocket One Inc. Common Stock compare to iBio?

Summary

How does Rocket One Inc. Common Stock compare to Talphera?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKTO vs. The Competition

Rocket One Inc. Common Stock Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rocket One Inc. Common Stock (RKTO) Competitors

RKTO vs. UPXI, XBIT, SPRO, IBIO, and TLPH

How does Rocket One Inc. Common Stock compare to Upexi?

Which has more risk & volatility, RKTO or UPXI?

Does the media refer more to RKTO or UPXI?

Do analysts prefer RKTO or UPXI?

Which has preferable valuation & earnings, RKTO or UPXI?

Is RKTO or UPXI more profitable?

Do institutionals & insiders hold more shares of RKTO or UPXI?

Summary

How does Rocket One Inc. Common Stock compare to XBiotech?

Does the media favor RKTO or XBIT?

Which has more risk & volatility, RKTO or XBIT?

Which has stronger earnings and valuation, RKTO or XBIT?

Do analysts recommend RKTO or XBIT?

Is RKTO or XBIT more profitable?

Do insiders and institutionals believe in RKTO or XBIT?

Summary

How does Rocket One Inc. Common Stock compare to Spero Therapeutics?

Is RKTO or SPRO more profitable?

Which has more volatility & risk, RKTO or SPRO?

Do analysts recommend RKTO or SPRO?

Does the media favor RKTO or SPRO?

Do institutionals & insiders hold more shares of RKTO or SPRO?

Which has stronger valuation & earnings, RKTO or SPRO?

Summary

How does Rocket One Inc. Common Stock compare to iBio?

Does the media refer more to RKTO or IBIO?

Is RKTO or IBIO more profitable?

Which has better earnings and valuation, RKTO or IBIO?

Do insiders & institutionals hold more shares of RKTO or IBIO?

Do analysts recommend RKTO or IBIO?

Which has more risk and volatility, RKTO or IBIO?

Summary

How does Rocket One Inc. Common Stock compare to Talphera?

Is RKTO or TLPH more profitable?

Do analysts recommend RKTO or TLPH?

Which has preferable valuation & earnings, RKTO or TLPH?

Do institutionals & insiders believe in RKTO or TLPH?

Which has more volatility & risk, RKTO or TLPH?

Does the media refer more to RKTO or TLPH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RKTO vs. The Competition

Rocket One Inc. Common Stock Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools